HCGBSEHEALTHCARE GLOB. ENT. LTDMinimalNeutral
Announced Thu, 15 Oct, 2026 · 17:59 IST

Quarterly compliance certificate for share dematerialization under SEBI Regulation 74(5)

HCG · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.0%Reaction day
₹590.00
prior close
₹594.80
announcement price
After-mkt
timing
Nifty Microcap 250market+0.7%-0.7% vs market
Hospital peers, median of 26sector-0.7%+0.7% vs sector

On the reaction day the stock moved 0.7 pts less than Nifty Microcap 250 and 0.7 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-1.6
10m
-1.4
15m
-1.3
30m
-1.5
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.0+0.7-0.7-0.7+0.7
Next day
-3.4-1.0-2.4-1.7-1.7
2d
-7.0-3.6-3.4-3.5-3.5
3d
-5.1-4.5-0.6-4.2-0.9
4d
-6.8-6.8-0.0-5.3-1.5
5d
-3.4-6.4+3.0-4.9+1.5
1w
—————
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 26Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

HealthCare Global Enterprises has submitted a routine quarterly compliance certificate under SEBI Regulation 74(5) for the quarter ended September 30, 2026. The certificate, issued by the company's Registrar and Share Transfer Agent Kfin Technologies, confirms that all dematerialization and rematerialization requests for equity shares during the quarter were processed within 15 days, security certificates were mutilated and cancelled after due verification, and the register of members was updated with depository names. The filing has been shared with BSE and NSE and is also available on the company website. This is a standard procedural compliance submission.

Likely market impact

Routine regulatory compliance filing. No material impact on shareholders, operations, or stock price.